Sequenom Misrepresented Medical Advancements: Suit
Medical testing developer Xenomics Inc. is asking a New York state court to grant as much as $300 million in damages from a company it says breached a patent licensing agreement...To view the full article, register now.
Already a subscriber? Click here to view full article